Contingent negative variation: Difference between revisions
CSV import |
CSV import |
||
| Line 43: | Line 43: | ||
[[Category:Electrophysiology]] | [[Category:Electrophysiology]] | ||
[[Category:Cognitive neuroscience]] | [[Category:Cognitive neuroscience]] | ||
{{No image}} | |||
Revision as of 10:36, 10 February 2025
Contingent Negative Variation (CNV)
The Contingent Negative Variation (CNV) is a slow cortical potential change that occurs in the brain, typically observed using electroencephalography (EEG). It is a type of event-related potential (ERP) that reflects the brain's preparation for a motor response or cognitive task. CNV is particularly interesting in the study of attention, anticipation, and motor preparation.
History
The CNV was first described by William Grey Walter and his colleagues in the 1960s. They discovered this phenomenon while studying the brain's electrical activity in response to stimuli that required a timed motor response.
Characteristics
The CNV is characterized by a slow, negative shift in the EEG that occurs between two stimuli: the warning stimulus (S1) and the imperative stimulus (S2). The CNV begins after the presentation of S1 and reaches its peak just before S2, which typically requires a response.
Phases of CNV
The CNV can be divided into two main phases:
- Initial CNV (iCNV): This phase occurs immediately after the warning stimulus (S1) and is thought to reflect the orienting of attention and the initial processing of the stimulus.
- Terminal CNV (tCNV): This phase occurs closer to the imperative stimulus (S2) and is associated with motor preparation and anticipation of the response.
Neurophysiological Basis
The CNV is believed to originate from the cerebral cortex, particularly the frontal lobe and parietal lobe. It involves the activation of neural circuits related to attention, anticipation, and motor preparation. The neurotransmitter dopamine is thought to play a significant role in modulating CNV amplitude.
Clinical Significance
CNV has been studied in various clinical populations to understand its role in different neurological and psychiatric conditions. For example, alterations in CNV have been observed in patients with Parkinson's disease, schizophrenia, and attention deficit hyperactivity disorder (ADHD). These findings suggest that CNV can serve as a biomarker for certain cognitive and motor dysfunctions.
Research Applications
CNV is used in research to study:
- The mechanisms of attention and anticipation.
- The effects of pharmacological agents on cognitive and motor processes.
- The development of cognitive and motor skills in children and adolescents.
Measurement and Analysis
To measure CNV, researchers use EEG to record brain activity while participants perform tasks that involve a warning stimulus followed by an imperative stimulus. The CNV is analyzed by averaging the EEG signals across multiple trials to isolate the slow negative shift from other brain activity.
See Also
References
- Walter, W. G., Cooper, R., Aldridge, V. J., McCallum, W. C., & Winter, A. L. (1964). Contingent Negative Variation: An Electric Sign of Sensorimotor Association and Expectancy in the Human Brain. Nature, 203, 380-384.
- Tecce, J. J. (1972). Contingent negative variation (CNV) and psychological processes in man. Psychological Bulletin, 77(2), 73-108.